Cerebrospinal fluid CD4⁺ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein

References

• Amyes E, Hatton C, Montamat-Sicotte D, Gudgeon N, Rickinson A B, McMichael A J, Callan M F. 2003. Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection.. J Exp Med. 198: 903–911. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ascherio A, Munch M. 2000. Epstein-Barr virus and multiple sclerosis. Epidemiology. 11: 220–224. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cepok S, Jacobsen M, Schock S, Omer B, Jaekel S, Boddeker I, Oertel W H, Sommer N, Hemmer B. 2001. Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain. 124: 2169–2176. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ebers G C, Sadovnick A D, Risch N J. 1995. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature. 377: 150–151. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fazekas de St Groth S. 1982. The evaluation of limiting dilution assays 1982. J Immunol Methods. 49: R11–R23. [PUBMED], [INFOTRIEVE]
   Web of Science ®Google Scholar
• Fitch F W, Gajewski T F. 1997. In vitro assays for mouse lymphocyte function. Current protocols in immunology, Coligan J E, Kruisbeek A M, Margulies D H, Shevach E M, Strober W, New York, John Wiley & Sons, pp 3.13.1–3.13.14
   Google Scholar
• Furnari F B, Adams M D, Pagano J S. 1992. Regulation of the Epstein-Barr virus DNA polymerase gene. J Virol. 66: 2837–2845. [PUBMED]
   PubMedGoogle Scholar
• Gaudernack G, Lundin K E. 1989. Rapid immunomagnetic phenotyping of cells. J Immunogenet. 16: 169–175. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Gedde-Dahl T, 3rd, Eriksen J A, Thorsby E, Gaudernack G. 1992. T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides. Human Immunol. 33: 266–274
   Google Scholar
• Haahr S, Koch-Henriksen N, Moller-Larsen A, Eriksen L S, Andersen H M. 1995. Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study. Mult Scler. 1: 73–77. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Hickey W F, Hsu B L, Kimura H. 1991. T-lymphocyte entry into the central nervous system. J Neurosci Res. 28: 254–260. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Holmøy T, Vartdal F. 2004. Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells. J NeuroVirol. 10: 52–56
   PubMed Web of Science ®Google Scholar
• Holmøy T, Vartdal F, Vandvik B. 2003. T cells from multiple sclerosis patients recognize immunoglobulin G from autologous cerebrospinal fluid. Mult Scler. 9: 228–234
   Google Scholar
• Ishigami T, White C A, Pender P. 1998. Soluble antigen therapy induces apoptosis of autoreactive T cells preferentially in the target organ rather than in the peripheral lymphoid organs. Eur J Immunol. 28: 1626–1635. [CROSSREF], [PUBMED], [INFOTRIEVE]
   Google Scholar
• Kurtzke J F. 2000. Multiple sclerosis in time and space–geographic clues to cause. J NeuroVirol. 6(Suppl 2)134–140
   PubMedGoogle Scholar
• Lang H, Jacobsen L H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherpfennig K, Stuart D I, Bell J I, Jones E Y, Fugger L. 2002. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol. 3: 940–943. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Levin L I, Munger K L, Rubertone M V, Peck C A, Lennette E T, Spiegelman D, Ascherio A. 2003. Multiple sclerosis and Epstein-Barr virus. JAMA. 289: 1533–1536. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Li, Pira G, Oppezzi L, Seri M, Westby M, Caroli F, Fenoglio D, Lancia F, Ferraris A, Bottone L, Valle M T, Kunkl A, Romeo G, Dalgleish A G, Manca F. 1999. Repertoire breadth of human CD4+ T cells specific for HIV gp120 and p66 (primary antigens) or for PPD and tetanus toxoid (secondary antigens).. Hum Immunol. 59: 137–148
   Google Scholar
• Martyn C N, Cruddas M, Compston D A. 1993. Symptomatic Epstein-Barr virus infection and multiple sclerosis. J Neurol Neurosurg Psychiatry. 56: 167–168. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Mason D. 1988. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today. 19: 395–404
   Google Scholar
• Morre S A, van, Beek J, De, Groot C J, Killestein J, Meijer C J, Polman C H, van der, Valk P, Middeldorp J M, van Den, Brule A J. 2001. Is Epstein-Barr virus present in the CNS of patients with MS?. Neurology. 56: 692, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Munch M, Hvas J, Christensen T, Moller-Larsen A, Haahr S. 1998. A single subtype of Epstein-Barr virus in members of multiple sclerosis clusters. Acta Neurol Scand. 98: 395–399. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Oldstone M B. 1987. Molecular mimicry and autoimmune disease. Cell. 50: 819–820. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ota K, Matsui M, Milford E L, Mackin G A, Weiner H L, Hafler D A. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346: 183–187. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Pender M P, Csurhes P A, Greer J M, Mowat P D, Henderson R D, Cameron K D, Purdie D M, McCombe P A, Good M F. 2000. Surges of increased T cell reactivity to an encephalitogenic region of myelin proteolipid protein occur more often in patients with multiple sclerosis than in healthy subjects. J Neuroimmunol. 165: 5322–5311
   Google Scholar
• Selin L K, Varga S M, Wong I C, Welsh R M. 1998. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J Exp Med. 188: 1705–1715. [CROSSREF], [PUBMED], [INFOTRIEVE]
   Google Scholar
• Tejada-Simon M V, Zang Y C, Hong J, Rivera M, Zhang J Z. 2003. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol. 53: 189–197. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson. 2001. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol. 1: 75–82. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wucherpfennig K W, Strominger J L. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80: 695–705. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner H L, Hafler D A. 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med. 179: 973–984. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar